Eximis Surgical

Surgical Devices · Louisville, CO · Founded 2014 · Privately Held (backing)

Developer of a specimen removal device designed for laparoscopic surgery. Eximis Surgical is based in Louisville, CO and was founded in 2014. Its last known valuation is $18.7 million. It has raised $45 million across 8 recorded rounds; the latest was a $15.3 million early-stage round in Mar 2023.

Last price · $/share
—
Implied valuation
$18.7M
Total raised
$45.0M
Last round
Early Stage VC
Mar 2023

Eximis Surgical key facts

  • Developer of a specimen removal device designed for laparoscopic surgery.
  • Eximis Surgical’s last known valuation is $18.7M.
  • It has raised $45.0M across 8 recorded rounds; the latest was Early Stage VC ($15.3M) in Mar 2023.
  • Notable investors include MedTech Innovator, Springboard Enterprises, Innosphere Ventures, Daniel Weide, ForMED Ventures — 9 tracked in total.
  • Eximis Surgical has filed 10 Form Ds with the SEC since 2015, most recently May 2024 ($15.3M sold to 12 investors).
  • Status: Privately Held (backing).
Free account
More of Eximis Surgical with a free account
  • ·Watch Eximis Surgical: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Eximis Surgical funding rounds

8 rounds
Mar 2023Early Stage VC$15.3MSEC filing▮
Oct 2018Early Stage VC$17.0MSEC filing▮
Feb 2018Early Stage VC$5.1MSEC filing▮
Jan 2018Accelerator/Incubator—▮
Dec 2017Seed Round$1.2MSEC filing▮

Eximis Surgical valuation

Eximis Surgical's last known valuation is $18.7 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.

How much has Eximis Surgical raised?

Eximis Surgical has raised $45 million across 8 recorded rounds since 2015. The largest was a $914,999 seed round in Sep 2015; the most recent was a $15.3 million early-stage round in Mar 2023.

Eximis Surgical has filed 10 Form Ds with the SEC since 2015, most recently in May 2024 ($15.3 million sold to 12 investors).

Eximis Surgical investors

9 investors are on record for Eximis Surgical, including MedTech Innovator, Springboard Enterprises, Innosphere Ventures and Daniel Weide. The early-stage round in Mar 2023 drew 12 investors.

Comparable companies

Comparable surgical devices names by valuation on PrivateMarketView: Imperative Care ($1.6 billion), SpyGlass Pharma (NAS: SGP) ($511 million) and FEMSelect ($17 million).

About Eximis Surgical

Developer of a specimen removal device designed for laparoscopic surgery. The company's device integrates into physician protocols and reduces the time for laparoscopic specimen removal, reduces patient discomfort, delivers safe outcomes, separates the specimen into narrow stripes, and creates clean tissue segments for pathology identification, enabling surgeons to have minimally invasive surgery.

Industry
Surgical Devices
Sector
Healthcare
HQ
Louisville, CO, United States
Founded
2014
Employees
13
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.

Valuation on record
$18.7M

Eximis Surgical’s last known valuation. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.